Catalyst Wire Dossier Catalyst Wire Dossier

House dust mite allergen extracts for sublingual immunotherapy

· Roxall Medizin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for House dust mite allergen extracts for sublingual immunotherapy, covering 2015-11-03 to 2015-11-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual Immunotherapy [Phase 3]

See pricing